Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Countries may need to "give up" swine flu vaccine to most vulnerable countries, reveals new research

19.10.2009
* Countries should be prepared to sacrifice their vaccines in a coordinated fashion - it might be in their best interests
* Lack of centralized, global coordination to contain the spread of infection may result in significantly greater infections

As countries begin stockpiling swine flu vaccines to deal with an anticipated "second wave" outbreak, research from the European School of Management & Technology (ESMT) in Berlin and Duke University in North Carolina warns that countries should be prepared to sacrifice their vaccines to more vulnerable countries in the face of a critical outbreak.

The research suggests that this may prove the best method of minimizing the total number of people infected globally and containing the spread of the disease across geographies.

The study uses a sophisticated mathematical model that represents the dynamics of an epidemic taking hold, factoring in the character of initial infections, the spread of the disease and drug efficacy. Using economic 'game theory', the research models how countries with drug supplies should respond to an epidemic in a neighboring country with little or no supplies of their own, when the objective is to protect their respective populations.

While accepting the political cost of sacrificing supplies to other nations, the research concludes that at the very least some countries will have to face up to the reality of giving up all their drug stockpiles to contain the pandemic globally. The ideal solution would be centralized decision-making and deployment of drugs, by an agency such as the World Health Organization (WHO). In this area, the study highlights the fundamental tension that world governments will face in effectively combating a global outbreak: the current lack of centralized control.

The research concludes that having a centralized planner take ownership and allocate drugs to the country first affected by outbreak would result in the best global containment of infection, and typically benefit all countries including those giving up drugs. Yet as richer nations begin to stockpile vaccines to deal with a national outbreak, the reality is that individual nations will be faced with the decentralized decision about whether or not to give away their supplies.

To be effective all countries will need to be prepared to give up their supplies, as only one or two nations' sacrifice would be futile. Moreover, the likelihood is that decentralized decision-making will leave countries locked in a 'prisoner's dilemma' - watching one another's actions, where no-one is prepared to make the first move. The research's modeling shows that only in half of these cases would individual countries reach the same decision as a central planner, resulting in around double the number of global infections than if centralized co-ordination were possible.

Francis de Véricourt, Professor at the European School of Management & Technology, explains: "Drug allocation will not be as effective when the decision-makers are individual governments, which in turn will dramatically increase the chance of infection from abroad. What is needed is for nations to come together and agree a shared drug allocation strategy. In reality, this is in their 'selfish' best interest as it will result in the best chance of arresting the spread of the disease including, potentially, to their own shores. Nonetheless, the political risk of sacrificing vaccines is clearly enormous. The inefficiency of decentralized action is not necessarily about free-riding off the generosity of another state - it is the very real and difficult decision facing political leaders about how best to act."

Recent events have shown that some progress is being made towards more centralized thinking, with nine countries (including the US and UK) pledging to give up 10 per cent of their supplies to help fight the spread of infection internationally. At present, the majority of drugs have been purchased by richer nations considered at less risk, with most vaccines being produced in Western Europe, North America and Japan. However, the UN has called for much greater donation, claiming that £900m needs to be raised to help poorer nations fight the onset of a global epidemic that could kill millions. According to flucount.org, the number of reported H1N1 infections now stands at 473,774 across the globe. At the start of this week, the site reported that 352 people had died from H1N1 deaths in the previous seven days - an increase of 9.3% on the previous week.

Francis de Véricourt concludes:
"The outcome of our study is clearly disturbing because while it is apparent that centralized drug allocation is the best solution worldwide, it can sometimes result in significant discrepancies between nations. Where the central planner's drug allocation typically benefits all countries, our research still highlights circumstances where a centralized decision would hurt some drug-possessing countries. Certain countries stand to benefit considerably while others could actually suffer a greater number of infections, or worse fatalities, than if they had acted purely in their own interests and hoarded their supplies. This is a global crisis which requires some global thinking. A common objective is critical."
Should you wish to speak to Francis de Véricourt, or find out more information about the study, please contact:
Contact
Kristin Dolgner
Tel.: +49 (0)30 21231-1066
kristin.dolgner@esmt.org
Martha Ihlbrock
Tel.: +49 (0)30 21231-1043
martha.ihlbrock@esmt.org
About ESMT
ESMT European School of Management and Technology was founded in October 2002 by 25 leading global companies and institutions. The international business school offers Full-time MBA and Executive MBA programs, as well as executive education in the form of open enrollment and customized programs. The School also features in-house research-oriented consulting services in the areas of competition and regulation. ESMT is a private university based in Berlin, Germany, with an additional location in Schloss Gracht near Cologne.

Martha Ihlbrock | idw
Further information:
http://www.esmt.org

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>